Triglycerides and Cardiovascular Risk

Author(s): K. E.L. Harchaoui, M. E. Visser, J. J.P. Kastelein, E. S. Stroes, G. M. Dallinga-Thie

Journal Name: Current Cardiology Reviews

Volume 5 , Issue 3 , 2009

Become EABM
Become Reviewer
Call for Editor


In 1996 a meta-analysis was published showing that an increase in plasma triglyceride (TG) levels was associated with an increase in CHD risk, even after adjustment for high density lipoprotein cholesterol (HDL-C) levels. Very recently, two studies were published that further extent the early observation and showed the importance of nonfasting plasma triglyceride (TG) levels in the prediction of risk on coronary heart disease (CHD). In the current review we have summarized all available evidence obtained in clinical studies showing that treatment guidelines should reconsider to include nonfasting TG in their risk assessments as nonfasting TG levels may better predict CVD risk.

Keywords: Triglycerides, coronary heart disease, lipoproteins, lipolytic enzymes

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [216 - 222]
Pages: 7
DOI: 10.2174/157340309788970315
Price: $65

Article Metrics

PDF: 3